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Group 2 innate lymphoid cells (ILC2) are innate
lymphocytes that confer protective type 2 immunity
during helminth infection and are also involved in
allergic airway inflammation. Here we report that
ILC2 development required T cell factor 1 (TCF-1,
the product of the Tcf7 gene), a transcription factor
also implicated in T cell lineage specification. Tcf7/
mice lack ILC2, and were unable to mount ILC2-
mediated innate type 2 immune responses. Forced
expression of TCF-1 in bone marrow progenitors
partially bypassed the requirement for Notch
signaling in the generation of ILC2 in vivo. TCF-1
acted through both GATA-3-dependent and GATA-
3-independent pathways to promote the generation
of ILC2. These results are reminiscent of the critical
roles of TCF-1 in early T cell development. Hence,
transcription factors that underlie early steps of
T cell development are also implicated in the devel-
opment of innate lymphoid cells.
INTRODUCTION
Recent studies have identified innate lymphocytes that lack
antigen receptors but functionally match subsets of T helper
cells (Spits and Cupedo, 2012). Group 2 innate lymphoid cells
(ILC2) produce T helper type 2 (Th2) cell-associated cytokines
interleukin-5 (IL-5) and IL-13 and mediate innate type 2 immunity
at airway and gut mucosa (Barlow et al., 2012; Chang et al.,
2011; Halim et al., 2012a; Mjo¨sberg et al., 2011; Monticelli
et al., 2011; Moro et al., 2010; Neill et al., 2010; Price et al.,
2010; Wilhelm et al., 2011). ILC2 provide protective immunity
to helminth infection because they are the predominant early
source of type 2 cytokines (Moro et al., 2010; Neill et al., 2010;
Price et al., 2010). ILC2 have also been implicated in allergic
airway inflammation and in lung epithelial repair (Barlow et al.,
2012; Chang et al., 2011; Halim et al., 2012a; Monticelli et al.,
2011; Wilhelm et al., 2011). The development of ILC2 requires
the transcription factors Id2, RORa, and GATA-3 (Halim et al.,694 Immunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc.2012b; Hoyler et al., 2012; Moro et al., 2010; Wong et al.,
2012). However, other transcription factors implicated in the
generation and function of ILC2 remain to be identified.
ILC2 share many similarities with T cells. ILC2 derive from
lymphoid progenitors and phenotypically resemble double-
negative 3 (DN3) cells that are committed to the T cell lineage
(Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Wong
et al., 2012; Yang et al., 2011). They also produce Th2 cell-
associated cytokines and express genes characteristic of
T cells (Moro et al., 2010; Wong et al., 2012). However, they
lack the antigen-specific T cell receptor (TCR) or pre-TCR and
develop normally in athymic mice (Moro et al., 2010). Neverthe-
less, the similarities between T cells and ILC2 suggest that
similar transcription factors may underlie the development of
these two lineages.
Here, we report that the development of ILC2 required TCF-1,
a transcription factor earlier shown to be important for T cell-fate
specification (Germar et al., 2011; Okamura et al., 1998; Verbeek
et al., 1995; Weber et al., 2011). Tcf7/ mice lacked ILC2 at
many anatomic sites and were compromised in immune
responses that required ILC2, including responses to the nema-
tode Nippostrongylus brasiliensis and protease allergen. We
found that upstream of TCF-1, Notch signaling is required for
the efficient generation of ILC2 in vivo. We further show that
forced expression of TCF-1 in hematopoietic progenitors
partially bypassed the requirement for Notch signaling in ILC2
development. Forced expression of TCF-1 also resulted in upre-
gulated expression of ILC2 cytokine receptors through both
GATA-3-dependent and GATA-3-independent mechanisms.
Thus, transcriptional regulatory events that underlie early T cell
development also direct the generation of ILC2, suggesting a
close developmental relationship between T cells and innate
lymphoid cells.
RESULTS
ILC2 Express T Lineage Genes
During early T cell development, bone marrow lymphoid progen-
itors home to the thymus, gradually lose alternative lineage
potentials and express T cell genes (Love and Bhandoola,
2011). Once progenitors enter the thymus, T cell-fate specifica-
tion and commitment are initiated by intrathymic Notch signals
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Figure 1. TCF-1 Is Required for ILC2 Development
(A) Flow plots show a representative analysis of ILC2 in the lungs of Tcf7+/+ and Tcf7/ mice. Plots were gated on CD45+ lung cells.
(B) Bar graph shows cellularity of lung ILC2 in Tcf7+/+ and Tcf7/ mice. Data are from eight mice per group (error bars are SEM).
(C) Flow plots show a representative analysis of bone marrow immature ILC2 in Tcf7+/+ and Tcf7/ mice. Plots were gated on Lin cells.
(D) Bar graph shows cellularity of bone marrow immature ILC2. Data are from three or four mice per group (error bars are SEM).
(E) We mixed 5,000 LSK cells from WT, Tcf7/ and poly(I:C)-treated Ctnnb1(encoding b-catenin)f/f Mxcre mice (CD45.2) with 2,500 WT competitor LSK cells
(CD45.1) and together injected them into lethally irradiated (950 rads) WT recipients (CD45.1). Reconstitution of lung ILC2 and splenic B cells was examined at
4 weeks posttransplant. Deletion of Ctnnb1 in LSK cells was confirmed by PCR (data not shown).
(F) Bar graph shows relative ILC chimerism normalized to splenic B cells. Results are from two independent experiments; fivemice per group (error bars are SEM).
(G) We intravenously transferred 5,000 LSK cells fromWTmice (CD45.1) into lethally irradiated Tcf7+/+ and Tcf7/mice (CD45.2). Development of lung ILC2 was
examined at 4 weeks posttransplant. Data are from two independent experiments; three mice per group (error bars are SEM; ns, not significant). **p < 0.05. See
also Figure S1.
Immunity
TCF-1 in ILC2 Developmentthat upregulate expression of transcription factors such as
TCF-1 and GATA-3 (Rothenberg, 2012). Interestingly, many
phenotypic and gene expression similarities between ILC2 and
T cells have been noted (Moro et al., 2010; Spits and Cupedo,
2012; Wong et al., 2012). For example, ILC2 from mesenteric
fat-associated lymphoid clusters (FALC) express genes charac-
teristic of T cells and T cell progenitors such as Gata3 and Lck
(Moro et al., 2010). Also, ILC2 generated in vitro with OP9-DL1
coculture express Tcf7 (the gene for TCF-1) and Bcl11b (Wong
et al., 2012). Therefore, we compared the amount of key T line-
age transcription factors and also T cell structural genes in
ILC2, DN3 cells, and bone marrow multipotent progenitors. For
these experiments, we used ILC2 obtained from the lungs of
Rag1/ mice to eliminate potential contamination with T cells.
We confirmed the expression of Tcf7, Gata3, Bcl11b, and Lck
by ILC2 (see Figure S1 available online). We found that lung
ILC2 also expressedmany other genes that are highly expressed
by T-lineage-committed DN3 progenitors. These moleculesincluded the Notch target genes Hes1 and Dtx1 and the TCR
signaling molecule Lat (Figure S1). ILC2 and DN3 cells also ex-
pressed comparable amounts of several cytokine receptors,
including Il7ra, Il17rb, and Il2ra. These results suggest that the
transcription factors implicated in T cell-fate specification might
also be involved in the generation or function of ILC2.
ILC2 Development Requires TCF-1
TCF-1, a T cell-specific high-mobility group (HMG) box tran-
scription factor, is necessary for normal T lineage specification
(Germar et al., 2011; Okamura et al., 1998; Verbeek et al.,
1995; Weber et al., 2011). Forced expression of TCF-1 in bone
marrow multipotent progenitors upregulates the expression of
many T lineage genes and cytokine receptors that are also ex-
pressed by ILC2 (Weber et al., 2011). We thus asked whether
TCF-1 is required for ILC2 cell development. The number of
ILC2 in the lungs of Tcf7/ mice was reduced to approximately
5% of the number in wild-type (WT) mice (Figures 1A and 1B).Immunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc. 695
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TCF-1 in ILC2 DevelopmentThe recently described bonemarrow immature ILC2 (Halim et al.,
2012b; Hoyler et al., 2012) were nearly absent in Tcf7/ mice
(Figures 1C and 1D). These data indicate that TCF-1 is required
for the generation of ILC2.
We next investigated whether the ILC2 developmental defect
in Tcf7/ mice was intrinsic to hematopoietic cells. Tcf7/
hematopoietic progenitors failed to give rise to ILC2 in irradiated
WTmice (Figures 1E and 1F), whereasWT bonemarrow progen-
itors developed normally into ILC2 in irradiated Tcf7/ recipient
mice (Figure 1G). TCF-1 can function with b-catenin to mediate
canonical Wnt signaling; however, TCF-1 drives early T cell
development independently of b-catenin (Cobas et al., 2004;
Jeannet et al., 2008; Weber et al., 2011). Similarly, we found
that b-catenin was dispensable for the generation of ILC2 (Fig-
ures 1E and 1F). Thus, as in early T cell development, TCF-1 is
required for ILC2 development in a hematopoietic cell-intrinsic
and b-catenin-independent manner.
The innate lymphoid cell family includes at least three subsets:
ILC2, natural killer (NK) cells, and RORgt+ innate lymphoid cells
(Spits and Cupedo, 2012). TCF-1 was previously implicated in
NK cell development (Held et al., 2003). We found that the
number of RORgt+ innate lymphoid cells in Tcf7/ mice was
also reduced, to 20%–50% of the number in WT mice (data
not shown). Thus, TCF-1 is involved in development of several
innate lymphocyte subsets. However, because TCF-1 appeared
most strictly required in the generation of ILC2, we focused on
understanding the role of TCF-1 in ILC2 development in the
present study.
ILC2-Mediated ImmuneResponses AreCompromised in
Tcf7–/– Mice
We wished to establish whether immune responses that require
ILC2 are compromised in Tcf7/ mice. Recent studies suggest
a critical role for ILC2 in mediating protease-induced airway
inflammation (Halim et al., 2012a; Oboki et al., 2010; Wilhelm
et al., 2011). We examined the responses of Tcf7/ and control
WT mice to intranasal challenge with papain, which has been
shown to induce rapid IL-5 production and eosinophilic infiltra-
tion in the airway (Halim et al., 2012a; Oboki et al., 2010; Wilhelm
et al., 2011). Consistent with previous reports (Halim et al.,
2012a; Oboki et al., 2010), intranasal challenge with papain
induced eosinophilic infiltration in the bronchoalveolar lavage
(BAL) and lungs of WT mice at 60 hr, and ILC2 produced IL-5
and IL-13 in the lung (Figures 2A and 2B). Tcf7/mice, however,
had very few IL-5 and IL-13 producing ILC2 (Figures 2A and 2B).
The few remaining Tcf7/ ILC2 were ineffective in producing
IL-5 and IL-13 (Figures S2A and S2B). The amounts of BAL
IL-5 and IL-13 were significantly reduced in Tcf7/ mice (Fig-
ure 2C), and airway eosinophilic infiltration was not observed
(Figures 2D and 2E). TCF-1 may also promote the differentiation
of Th2 cells and NK T cells (Ohteki et al., 1996; Yu et al., 2009),
which are capable of producing Th2 cell-associated cytokines
(Stock et al., 2009; Terashima et al., 2008). However, eosino-
philic infiltration was observed in papain-challenged Rag2/
mice lacking NKT cells and T cells (Halim et al., 2012a; Oboki
et al., 2010). Thus, defects in TCR-negative cells, such as
ILC2, are likely responsible for the complete absence of airway
eosinophilic infiltration in Tcf7/ mice. We next transferred
WT ILC2 into Tcf7/ mice. We transferred 105 WT ILC2 that696 Immunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc.were expanded in vivo by IL-33 treatment into each Tcf7/
mouse. This manipulation resulted in partial restoration of ILC2
cell numbers in the lung (Figure 2F). Consistently, transfer of
WT ILC2 partially restored eosinophilic infiltration in the BAL
and lungs of Tcf7/mice in responses to papain challenge (Fig-
ure 2G). Together, these data establish that Tcf7/ mice lack
functional ILC2 in the lung.
ILC2 are systemically dispersed cells (Price et al., 2010). Pre-
vious studies have demonstrated that ILC2 are the predominant
early source of type 2 cytokines and can promote protective im-
munity to helminth infection with Nippostrongylus brasiliensis
(Moro et al., 2010; Neill et al., 2010; Price et al., 2010). Therefore,
we examined the responses of Tcf7/ mice to N. brasiliensis
infection. N. brasiliensis infection induced the expansion of
ILC2 in multiple sites including the BAL, lungs, and mesenteric
lymph nodes of WT mice at 10 days postinfection (Figures 3A
and 3B). Tcf7/ mice, however, lacked ILC2 at all of these sites
(Figures 3A and 3B). Eosinophilic infiltration was observed in
the lungs of WT mice in responses to N. brasiliensis infection,
whereas Tcf7/ mice lacked these responses (Figure 3C).
Tcf7/ mice were also inefficient at expelling worms from the
intestine (Figure 3D). Adoptive transfer of WT ILC2 from IL-33
treated mice restored worm clearance and lung eosinophilic
infiltration in N. brasiliensis infected Tcf7/ mice (Figures 3C
and 3D). The purpose of IL-33 treatment is to obtain sufficient
numbers of ILC2 for adoptive transfer; whether transfer of unex-
panded ILC2 from naive mice may confer similar protective
immunity to helminth infection in Tcf7/ mice requires further
studies. Nevertheless, these results indicate that Tcf7/ mice
lack functional ILC2 at multiple sites and are unable to establish
protective immunity to helminth infection.
A small number of ILC2 remained evident in the lungs of
Tcf7/ mice (Figures 1A and 1B). To understand the develop-
ment and function of these Tcf7/ ILC2, we isolated these cells
for gene expression analysis. We examined the expression of
Lef1, another member of the TCF and LEF transcription factor
family. LEF-1 shares structural features with TCF-1 (Hurlstone
and Clevers, 2002), and may compensate for TCF-1 deficiency
in NK and T cell development (Held et al., 2003; Okamura
et al., 1998; Yu et al., 2012). Expression of Lef1 was elevated
approximately 4.5-fold in Tcf7/ ILC2 compared to WT ILC2,
suggesting compensatory upregulation (Figure S7A). Tcf7/
ILC2 expressed Gata3 and Il7r, but the amounts were reduced
to approximately 30% to 50% of the amounts in WT ILC2 (Fig-
ure S3), suggesting that TCF-1 might normally regulate Gata3
and Il7r expression in ILC2. WT and Tcf7/ ILC2 exhibited
a comparable cell-cycle profile and Annexin V staining (Fig-
ure S7B–S7E). Haploinsufficiency of GATA-3 or overexpression
of LEF-1 has been shown to impair the expression of type 2
cytokines, such as Il4 and Il5 (Hebenstreit et al., 2008; Hosoya
et al., 2009; Zhu et al., 2004). Indeed, Tcf7/ ILC2 expressed
less mRNA for type 2 cytokines Il5 and Il13 (Figure S3), and the
amounts remained lower than those of WT cells in responses
to papain challenge (Figure S2). Hence, the few ILC2 that
develop in the absence of TCF-1 are functionally compromised.
Notch Promotes ILC2 Development
We investigated the upstream signals that elicit TCF-1 expres-
sion during ILC2 development. Notch signals directly upregulate
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Figure 2. Tcf7–/– Mice Lack Functional ILC2 in the Lung
(A and B) Tcf7+/+ and Tcf7/ mice were intranasally challenged with papain (10 mg in 40 ml of PBS) every 24 hr on day 0, day 1, and day 2. Mice were sacrificed
12 hr after the last challenge. Lung hematopoietic cells were isolated and stimulated with PMA (50 ng/ml) and ionomycin (500 ng/ml) in the presence of monensin
for 3 hr. Cells were stained for ILC2 followed by intracellular staining of IL-5 and IL-13.
(C) IL-5 and IL-13 concentrations in the BAL fluid from papain-treated mice were measured by ELISA. Data are from four mice (error bars are SEM). **p < 0.05.
(D and E) Eosinophils in BAL and lungs were examined by flow cytometry analysis. Flow plots were gated on CD45+ cells. We used the combination of CD11c and
Siglec-F to distinguish airway macrophages and eosinophils as described (Dyer et al., 2011). The CD11cSiglec-F+ cells were further confirmed to be SSChigh
cells (data not shown). Data are from three to five mice per group (error bars are SEM).
(F) We intravenously transferred 105 WT ILC2 into Tcf7/ mice 8 hr before the first challenge with papain. The restoration of lung ILC2 was examined by flow
cytometry analysis 12 hr after the final challenge. Flow plots were gated on Lin cells.
(G) The number of eosinophils in papain challenged Tcf7+/+ mice, Tcf7/mice, and Tcf7/mice with adoptive transfer of WT ILC2 is shown. Data are from three
to four mice per group (error bars are SEM). **p < 0.05. See also Figure S2.
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TCF-1 in ILC2 DevelopmentTCF-1 expression during early T cell development (Germar et al.,
2011; Weber et al., 2011). Notch also promotes the generation of
ILC2 in vitro (Wong et al., 2012); however, a role for Notch in ILC2
development in vivo remains to be established. By using retro-
viral dominant-negative Mastermind like-1 (dnMAML), a pan-
Notch inhibitor (Maillard et al., 2006), we confirmed that Notch
signaling is required for ILC2 generation in vivo. DnMAML-ex-
pressing multipotent bone marrow progenitors (LinSca-1+Kit+or LSK cells) failed to efficiently give rise to ILC2 in vivo (Figures
4A and 4B). Cotransduction of Tcf7 retrovirus partially restored
the generation of ILC2 from dnMAML-expressing LSK cells (Fig-
ures 4A and 4B). To determine whether the ILC2 generated from
Tcf7 and dnMAML cotransduced progenitors were functional,
we cultured them with the cytokines IL-2, IL-7, and IL-33, which
were reported to induce the production of type-2 cytokines by
ILC2 (Moro et al., 2010). These cells produced IL-5 and IL-13Immunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc. 697
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Figure 3. Tcf7–/– Mice Lack ILC2-Mediated
Immune Responses to Helminth Infection
Tcf7+/+ and Tcf7/ mice were infected with 500
L3 stage N. brasiliensis worms by subcutaneous
transfer and sacrificed at 10 days after infection.
(A) Flow plots show a representative analysis of
ILC2 in the mesenteric lymph nodes (mLN) of
TCF-1+/+ and Tcf7/ mice. Plots were gated on
Lin CD45+ cells.
(B) Bar graphs show the numbers of ILC2 in the
BAL, lungs, andmLN. Data are from eight mice per
group (error bars are SEM). **p < 0.05.
(C) We transferred 105 WT ILC2 into Tcf7/ mice
at day 0 and again at day 5 after infection. The
number of eosinophils in the lungs in Tcf7+/+ mice,
Tcf7/ mice, and Tcf7/ mice with adoptive
transfer of WT ILC2 is shown. Data are from four to
six mice per group (error bars are SEM). **p < 0.05.
(D) The number of intestinal worms in
N. brasiliensis infected mice was assessed. Data
are from four to six mice per group (error bars are
SEM). **p < 0.05. See also Figure S3.
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TCF-1 in ILC2 Development(Figure 4C) and expressed Gata3 (Figure 4D), suggesting they
were functional ILC2. Together, these data indicate that TCF-1
acts downstream of Notch signaling during ILC2 development.
Like Tcf7, Hes1 is another direct Notch target that is critically
involved in early T cell development (Tomita et al., 1999). The
expression of Hes1 during early T cell development does not
require TCF-1 (Weber et al., 2011). Because Hes1 is expressed
by ILC2 (Figure S1), we examined whether HES-1 is involved in
ILC2 development in vivo. Hes1/ fetal liver progenitors failed
to efficiently develop into T cells as expected, but they differen-
tiated into ILC2 normally in the lungs of irradiated recipients (Fig-
ures 4E and 4F). Taken together, these data indicate that Notch
signaling regulates ILC2 development through TCF-1 dependent
but HES-1 independent pathways.
TCF-1 Promotes ILC2 Development through GATA-
3-Dependent and GATA-3-Independent Pathways
We investigated the mechanisms through which TCF-1 pro-
motes ILC2 development. TCF-1 promotes the survival of thy-
mocytes by maintaining the expression of Bclxl (Goux et al.,
2005); however, ectopic expression of BclXL or Bcl2 does not
rescue the early T cell development defects in Tcf7/ mice698 Immunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc.(Goux et al., 2005; Wang et al., 2011;
Weber et al., 2011). Similarly, ectopic
expression of BclXL did not rescue the
generation of ILC2 from Tcf7/ bone
marrow progenitors in vivo (Figure S4),
suggesting that TCF-1 is not exclusively
required for the survival of ILC2.
To understand how enforced expres-
sion of TCF-1 in bonemarrow progenitors
can bypass the Notch requirement for
ILC2 development, we examined the
expression of ILC2 genes in these pro-
genitors. Forced expression of TCF-1
in multipotent bone marrow LSK cells
rapidly upregulated the expression ofseveral ILC2 cytokine receptors (Il7r, Il17rb, and Il2ra) as well
as transcription factor Gata3 (Figure 5A). These cytokine recep-
tors were previously reported to promote the generation or func-
tion of ILC2 (Moro et al., 2010; Neill et al., 2010; Wilhelm et al.,
2011). GATA-3 is similarly essential for the generation and main-
tenance of ILC2 (Hoyler et al., 2012; Liang et al., 2012; Mjo¨sberg
et al., 2012). These data indicate that TCF-1 may direct ILC2
development by upregulatingGata3 and important ILC2 cytokine
receptor genes.
Because ectopic expression of GATA-3 is highly detrimental to
the long-term survival and lymphoid-lineage differentiation of
hematopoietic progenitors (Taghon et al., 2007), we could not
examine the effects of ectopic expression of GATA-3 in vivo.
To further understand the mechanisms by which TCF-1 pro-
motes ILC2 development, we examined whether GATA-3 is
required for TCF-1 to upregulate the expression of ILC2 genes.
We first deleted GATA-3 from LSK cells by polyinosine-polycyti-
dylic acid [poly(I:C)] treatment of Gata3f/f Mxcre+ mice. GATA-
3-deficient LSK cells failed to develop into lung ILC2 when
transferred into irradiated recipient mice (Figure S5). These
results confirmed that GATA-3 is required for ILC2 development
in vivo (Hoyler et al., 2012). To test whether GATA-3 is required
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Figure 4. Notch Promotes ILC2 Development
(A and B) Bonemarrow LSK cells were transduced with control GFP, dnMAML-GFP, Tcf7-VEX, or cotransduced with dnMAML-GFP and Tcf7-VEX retrovirus. We
injected 105 cells into lethally irradiated (950 rads) recipients. Generation of lung ILC2 was examined at three weeks posttransplant. The number of donor-derived
ILC2 was normalized to bone marrow LSK cells. Data are from two independent experiments; three mice per group (error bars are SEM). **p < 0.05; ns, not
significant.
(C) An equal number of ILC2 that were derived from dnMAML-GFP and Tcf7-VEX retrovirus cotransduced LSK cells and from control-GFP retrovirus-transduced
LSK cells were cultured with 10 ng/ml of IL-2, IL-7, and IL-33 for 12 days. The concentrations of cytokines in the culture supernatant weremeasured by ELISA.WT
ILC2 cultured with IL-7 alone were used as a negative control. Data are from two independent experiments; three mice per group (error bars are SEM).
(D) The cultured ILC2 derived from dnMAML-GFP and Tcf7-VEX retrovirus cotransduced LSK cells and from control-GFP retrovirus transduced LSK cells were
collected. The amount of Gata3 mRNA was measured by quantitative reverse-transcription PCR.
(E and F) Hes1+/+ and Hes1/ fetal liver cells (CD45.2) were mixed with competitor wild-type bone marrow cells (CD45.1) at 1:3 ratio, and together injected into
lethally irradiated wild-type recipient mice (CD45.1). The reconstitution of the indicated populations in the lungs of recipient mice was examined at 8 weeks post-
transplant. Data represent 2 independent experiments; 3 mice per group (error bars are SEM). ns, not significant. See also Figure S4.
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TCF-1 in ILC2 Developmentfor TCF-1-mediated ILC2 gene upregulation, we transduced
GATA-3 deficient LSK cells with TCF-1 retrovirus. In the absence
of GATA-3, ectopic expression of TCF-1 failed to upregulate
expression of Il17rb and Il2ra but was sufficient for the upregula-
tion of Il7r expression (Figure 5A). Thus, TCF-1 likely upregulates
the expression of ILC2 cytokine receptors through both GATA-3-
dependent (for Il17rb and Il2ra) and GATA-3-independent (for
Il7r) mechanisms.We further investigated the regulation of Il7r by TCF-1. Like
TCF-1, IL-7Ra is involved in the generation of ILC2, RORgt+
innate lymphoid cells and T cell progenitors (von Freeden-Jeffry
et al., 1995; Vonarbourg et al., 2010). We therefore asked
whether TCF-1 may directly regulate Il7r expression. We identi-
fied a conserved TCF-1 binding site at –3.6 kb upstream of the
transcription initiation site of Il7r (Figure 5B), within a region pre-
viously described to be important for the regulation of Il7rImmunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc. 699
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Figure 5. TCF-1 Directly Regulates Expression of Il7r
(A) Tcf7-VEX or control-VEX retrovirus was transduced into LSK cells from poly (I:C) treated Gata3f/f Mxcre- or Gata3f/f Mxcre+ mice. VEX+ Cells were sorted at
60 hr post-transduction, and the amounts of mRNAwere examined by qRT-PCR. Data are from two independent experiments; three or four mice per group (error
bars are SEM). **p < 0.05; ns, not significant.
(B) A conversed TCF binding site was identified at a known upstream regulatory region of Il7r gene locus.
(C) We cotransfected 293T cells with Tcf7 (or control) retroviral vectors and a luciferase vector containing the 3.6 kb upstream regulatory region of murine Il7r
gene. TCF-1 (Tcf7) was able to upregulate luciferase reporter activity. The luciferase reporter activity was ablated when the TCF-1 binding site in the 3.6 kb
upstream regulatory region was mutated. Data are from two independent experiments. Error bars are SEM from triplicate samples.
(D) ILC2 from lungs of naive mice were expanded in vitro with IL-2, IL-7, and IL-33. ChIP showed that TCF-1 binds to the Gata3-1b promoter and the –3.6 kb
upstream regulatory region of Il7r locus in ex vivo expanded ILC2. DNA region lacking TCF-1 binding site was used as a negative control. Data are from two
independent experiments. Error bars are SEM from triplicate samples. **p < 0.05; ns, not significant. See also Figure S5.
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TCF-1 in ILC2 Developmentexpression (Lee et al., 2005). We cotransfected 293T cells
with Tcf7 retroviral vector and a luciferase reporter vector
containing the –3.6 kb upstream regulatory domain. We found
that coexpression with Tcf7 increased luciferase reporter
activity 25-fold (Figure 5C). Consistently, mutation of the TCF-1
binding site at the –3.6 kb upstream regulatory domain abol-
ished reporter activity (Figure 5C), indicating that TCF-1 may
control Il7r expression through this binding site. Chromatin
immunoprecipitation (ChIP) on ex vivo expanded ILC2 estab-
lished that TCF-1 binds to this regulatory region in ILC2
(Figure 5D). TCF-1 also binds to a previously reported Gata3-
1b regulatory region (Yu et al., 2009) in ILC2 (Figure 5D).
These results suggest TCF-1 may directly regulate Il7r expres-
sion in ILC2.
Because GATA-3 is required for TCF-1-mediated upregulation
of Il17rb and Il2ra, we investigated whether GATA-3may upregu-
late or maintain the expression of these cytokine receptors
during ILC2 development. We ectopically expressed GATA-3700 Immunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc.in LSK cells. Because ectopic expression of GATA-3 is detri-
mental to hematopoietic progenitors (Taghon et al., 2007), we
used short-term culture in which we observed minimal death of
progenitors. Forced expression of GATA-3 in LSK cells induced
the expression of Il2ra and Il17rb, but not Il7r (Figure 6A). We next
cultured lung ILC2 in vitro with IL-2, IL-33, and IL-7, and deleted
Gata3 by using MSCV-GFP-cre retrovirus. We confirmed effi-
cient deletion of Gata3 by using real-time PCR primers that
amplified the deleted exons (Figure S6A). Deletion of Gata3 in
ILC2 resulted in reduced expression of Il2ra, Il17rb, and to a
lesser extent Il1rl1 (encoding IL-33R) (Figure 6B). Expression of
Il7r, however, was not reduced after Gata3 deletion (Figure 6B).
Consistent with previous reports (Hoyler et al., 2012; Liang et al.,
2012; Mjo¨sberg et al., 2012), deletion of Gata3 in ILC2 also
greatly decreased expression of Il5 and Il13 (Figure 6B). Because
we used IL-33 for efficient retroviral transduction of ILC2, our
results establish roles for GATA-3 in IL-33 activated ILC2. These
results are consistent with the gene expression profile of ILC2
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(A) Gata3 or empty control retrovirus was transduced into LSK cells fromWT mice. GFP+ cells were sorted at 60 hr posttransduction, and the amounts of mRNA
were examined by qRT-PCR. Data are from two independent experiments; three or four mice per group (error bars are SEM).
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ns, not significant. See also Figure S6.
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TCF-1 in ILC2 Developmentdirectly isolated from naive Tcf7/ mice, in which we observed
reduced expression of Gata3 as well as Il5 and Il13 (Fig-
ure S7A), suggesting that these GATA-3-mediated gene
regulatory events are already established in ILC2 of naive mice
in vivo. GATA-3 deficient ILC2 grew inefficiently in vitro in the
presence of IL-2, IL-7, and IL-33 (Figure 6C). Cell-cycle analysis
showed a decreased percentage of actively cycling cells (Fig-
ures 6D and 6E). Annexin V staining did not reveal a defect in
survival (Figures S6B and S6C). To determine whether the
growth defects of Gata3/ ILC2 were associated with reduced
expression of Il7r or Il2ra, we next culturedWT and GATA-3-defi-cient ILC2 in the presence of IL-7 or IL-2 alone. Consistent with
the reduced expression of Il2ra but not Il7r after GATA-3 deletion,
GATA-3-deficient ILC2 grew normally in the presence of IL-7
alone, but they expanded poorly in the presence of IL-2 alone
(Figure 6F). These results indicate that GATA-3 upregulates
and maintains the expression of Il2ra, but not Il7r, during ILC2
development. Together, our data support a model of ILC2
development wherein TCF-1 acts downstream of Notch sig-
naling to control the expression of ILC2 cytokine receptors
Il17rb, Il2ra, and Il7r via both GATA-3-dependent and GATA-3-
independent mechanisms.Immunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc. 701
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TCF-1 in ILC2 DevelopmentDISCUSSION
We have identified a requirement for TCF-1 in the generation of
ILC2 and further established roles for Notch and GATA-3 in
this process. Our data suggest a striking similarity between early
T cell and ILC2 development. Like early T cell development,
Notch signaling is required for ILC2 development. Forced
expression of TCF-1 in bone marrow progenitors bypasses the
requirement for Notch signaling in ILC2 development, and
TCF-1 acts through both GATA-3-dependent and GATA-3-inde-
pendent mechanisms. Hence, the transcriptional regulatory
events that specify T cell fate are similarly implicated in the
development of some innate lymphoid cells.
During early T cell development, Notch signaling within the
thymus upregulates expression of TCF-1 in early thymic progen-
itors (ETP), and TCF-1 subsequently drives T lineage specifica-
tion (Germar et al., 2011; Weber et al., 2011). Strikingly, Notch
signaling is also required for ILC2 development. A previous
study showed that Notch signaling promotes ILC2 generation
in vitro (Wong et al., 2012), and the present study establishes
that a requirement for Notch signaling in ILC2 development is
also evident in vivo. Unlike T cells, ILC2 do not require the
thymus for their development (Moro et al., 2010). The anatomic
site(s) of ILC2 maturation, and the specific Notch ligands that
regulate ILC2 development, are interesting questions for future
studies. Notch signaling is also required for the proper develop-
ment of IL-22 producing innate lymphoid cells in the small intes-
tine lamina propria, but not those in the Peyer’s Patches (Lee
et al., 2012). Notch signaling is however dispensable for NK
cell development (Lee et al., 2012; Ribeiro et al., 2010). In
contrast, TCF-1 promotes efficient generation of both RORgt+
innate lymphoid cells and NK cells at distinct anatomic sites.
RORgt+ ILC were reduced in small intestine lamina propria,
mesenteric lymph nodes, and spleens of Tcf7/ mice, and
NK cells were reduced in bone marrow and spleens of Tcf7/
mice (Held et al., 2003; data not shown). These results indicate
that the expression of TCF-1 is likely controlled by Notch-inde-
pendent mechanisms during the development of these innate
lymphoid cell subsets. The nature of these mechanisms war-
rants future studies.
Although ILC2 share many developmental, molecular, and
functional similarities with T cells, they are also clearly distinct
from T cells. Unlike T cells, ILC2 lack antigen receptors and
develop normally in nude mice that only possess a rudimentary
thymus (Moro et al., 2010). How ILC2 cell fate is molecularly
distinct from T cell fate remains unresolved. Our results indicate
that ILC2 develop in a HES-1-independent manner, in contrast to
T cells, which require HES-1 downstream of Notch signaling. In
addition, like other innate lymphoid cells, ILC2 express high
amounts of Id2 and require Id2 for their development (Moro
et al., 2010). However, overexpression of Id2 in thymic progeni-
tors is detrimental to T cell development, suggesting unique
requirements for E-proteins in these lineages (Morrow et al.,
1999). Also, ILC2 development requires the orphan nuclear
receptor RORa, but not the thymocytes-specific isoform RORgt
(Halim et al., 2012b; Moro et al., 2010; Wong et al., 2012). The
overlapping and yet distinct mechanisms underlying the devel-
opment of T cells versus ILC2, as well as other innate lymphoid
cells, require further investigation.702 Immunity 38, 694–704, April 18, 2013 ª2013 Elsevier Inc.The transcriptional regulators that control both T cell and ILC2
development are reminiscent of similar genes expressed by
subsets of lymphocytes in lampreys. Jawless vertebrates lack
RAG and TCR genes and use a distinct molecular mechanism
to generate diversity among adaptive lymphocyte populations
that bear clonally distributed variable lymphocyte receptors
(VLR) (Guo et al., 2009). Lamprey lymphocytes include T-like
‘‘VLR-A’’ cells that express genes similar to the T-lineage genes
expressed by ILC2 and T cells in mice. Genes expressed by
lamprey T-like cells include Gata3, Bcl11b, and Notch1 (Guo
et al., 2009); whether orthologs of Tcf7 are expressed by lamprey
lymphocytes is unknown. Our study establishes roles for Notch,
TCF-1, and GATA-3 in the development of ILC2 in mice. We
speculate that transcriptional regulatory programs that establish
a T cell-like fate originated prior to RAG, TCR, and VLR during
evolution, in innate lymphoid cells. Our results indicate that
such regulatory programs continue to underwrite the develop-
ment of some innate lymphoid cells in addition to T cells in
vertebrates.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (CD45.2) and B6-Ly5.2 (CD45.1) mice were purchased from National
Institutes of Health or the Jackson Laboratory. Other mice used include
Tcf7/ mice (Verbeek et al., 1995), Ctnnb1f/f (encoding b-catenin) (Brault
et al., 2001), and Gata3f/f mice (Pai et al., 2003). All animal experiments were
performed according to protocols approved by the Institutional Animal Care
and Use Committee policies at the University of Pennsylvania.
Administration of Poly(I:C)
Gata3f/f Mxcre and Ctnnb1f/f Mxcre mice were treated with 0.2 mg poly(I:C)
(Sigma) intraperitoneally (i.p.) every other day for 5 times for in vivo deletion
of Gata3 or Ctnnb1. The mice rested for 10 days, and bone marrow LSK cells
were sorted by flow cytometry cell sorting.
Potease Allergen Challenge, Helminth Infection, and Adoptive
Transfer of ILC2
For protease challenge, 10 mg papain (in 40 ml of PBS) was intranasally admin-
istrated into WT or Tcf7/ mice every 24 hr on day 0, day 1, and day 2. Mice
were sacrificed at 12 hr after the last challenge. BAL fluid and lungs were
analyzed.
For Nippostrongylus brasiliensis infections, WT or Tcf7/ mice were in-
fected subcutaneously with 500 infective third-stage larvae (L3). Mice were
sacrificed at 10 days after infection for analysis of ILC2 responses. BAL fluid,
lungs, and mesenteric lymph nodes were analyzed, and worm counts were
performed.
For adoptive transfer of ILC2, lung ILC2 were isolated from WT mice
receiving 300 ng of recombinant mIL-33 (eBioscience) i.p. daily for 7 days.
We transferred 105 ILC2 into Tcf7/ mice on the same day of papain chal-
lenge or on day 0 and day 5 of N. Brasiliensis infection.
Isolation of Lung Hematopoietic Cells
Mice were exsanguinated and lungs were perfused by injecting 10 ml PBS into
the right ventricle of the heart. Lungs were carefully cut into small fragments
and digested in Hank’s balanced salt solution containing 0.025mg/ml Liberase
D (Roche Diagnostics) and 10 U/ml DNase I (Roche Diagnostics). Cells were
filtered by using a cell strainer.
Flow Cytometry and Cell Sorting
All antibodies (Abs) used were purchased from eBioscience unless specified
otherwise. Abs in the lineage (Lin) mixture included anti-FcεR (MAR-1), anti-
B200 (RA3-6B2), anti-CD19 (ID3), anti-Mac-1 (M1/70), anti-Gr-1 (8C5), anti-
CD11c (HL3), anti-NK1.1 (PK 136), anti-Ter-119 (Ter-119), anti-CD3 (2C11),
anti-CD8b (53.5.8), anti-TCRb (H57), and anti-gdTCR (GL-3). Additional Abs
Immunity
TCF-1 in ILC2 Developmentused included anti-CD45.2 (104), anti-CD45.1 (A20), anti-Kit (2B8), anti-Sca-1
(D7), anti-CD4 (GK1.5), anti-Thy1.2 (53-2.1), anti-IL-5 (TRFK5), anti-IL-13
(eBio13A), anti-Siglec F (E50-2440; BD Biosciences), and anti-ST2 (DJ8; MD
Bioproducts). Cell sorting was performed on a FACSAria II (BD Biosciences),
and flow cytometric analysis was performed on a LSR-II (BD Biosciences).
Intracellular staining was performed by using Cytofix/Cytoperm Kit (BD Biosci-
ences) according to the manufacturer’s instructions.
Bone Marrow Transplantation
For competitive bone marrow chimeras, 5,000 sorted LSK cells from donor
mice (CD45.2) were mixed with 2,500 competitor WT LSK cells (CD45.1 or
CD45.1+CD45.2+) and intravenously transferred into lethally irradiated (950
rads) WT recipient mice (CD45.1). For transplantation for fetal liver cells, fetal
liver cells (CD45.2) were mixed with competitor WT bone marrow cells
(CD45.1) at 1:3 ratio, and together transferred into lethally irradiated WT recip-
ient mice (CD45.1). Reconstitution of ILC2 in the recipient mice was examined
at the indicated time points.
For noncompetitive bone marrow chimeras, 5,000 sorted LSK cells from
donor mice were transferred into lethally irradiated WT or TCF-1/ recipients.
In some experiments, donor LSK cells were transduced with retrovirus,
and 105 cells were transferred into lethally irradiated recipients at 24 hr
posttransduction.
ChIP and Luciferase Reporter Assays
For ChIP, ILC2 were sorted from the lungs of naive mice and expanded in vitro
with 10 ng/ml IL-2, IL-7, and IL-33 for 2 weeks. ChIP was performed as we pre-
viously described (Weber et al., 2011). Primers to detect the TCF-1 binding site
in the –3.6 kb upstream regulatory region of Il7r locus are as follows: 50-GGTA
CAGCATGTGCTAGTTTGCT-30; and 50-TGATGTCCTTTCAGCATCTCC-30.
Primers to detect the TCF-1 binding site in the Gata3-1b promoter were
described previously (Yu et al., 2009).
For luciferase reporter assays, 293T cells were cotransfected with TCF-1 (or
control) retroviral vector and a previously described luciferase reporter vector
containing the –3.6 kb upstream regulatory region of Il7r locus (Lee et al.,
2005). Renilla was added at 50 ng/well for normalization of transfection effi-
ciency. Cells were harvested 48 hr after transfection and analyzed with a
Dual Assay Reporter Kit (Promega).
Cell Culture and Retroviral Transduction
Bone marrow LSK cells were cultured in DMEM medium with 15% fetal calf
serum (FCS), 100 ng/ml SCF, 6 ng/ml IL-3, and 5 ng/ml IL-6. Lung ILC2
were cultured in MEM-a medium with 20% FCS and 10 ng/ml of IL-7, IL-2,
and IL-33. Cytokines were purchased from Peprotech.
Retroviral supernatant preparation and retroviral transduction of LSKs were
performed as described (Weber et al., 2011). For retroviral transduction of
ILC2, sorted ILC2 from naive mice were cultured overnight with 10 ng/ml of
IL-7, IL-2, and IL-33. The addition of IL-33 is important because we obtained
very poor retroviral transduction efficiency with IL-2 and IL-7 only (data not
shown). The following day, cells were resuspended in retroviral supernatant
supplemented with the above cytokines, centrifuged at 1,400 g for 2 hr, and
cultured at 37C for a further 6 hr. Cells were then washed with PBS and
cultured in fresh medium with cytokines. GFP+ cells were sorted at the indi-
cated time points after retroviral transduction.
Elisa
The concentrations of IL-5 and IL-13 were measured by standard sandwich
Elisa (eBioscience) according to the manufacturer’s protocol.
Cell-Cycle Analysis and Apoptosis Assay
For cell-cycle analysis, cells were incubated with 10 mg/ml Hoechst 33342
(Invitrogen) at 37C for 45 min. Cells were washed with PBS, and flow
cytometry analyses were performed within 30 min. For apoptosis assays, cells
were stained with Annexin V (BD PharMingen) according to themanufacturer’s
protocol.
Statistics
Intergroup comparison was performed using Student’s t test. P values lower
than 0.05 were considered significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at http://dx.doi.org/10.1016/j.immuni.2012.12.003.
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